It was interesting on the most recent results call when CSL said demand for Albumin was very high. “They could sell all the albumin they could get their hands on”
now csl have announced they are doubling their albumin supply capacity :
In February, CSL Behring Broadmeadows welcomed its new filling line as part of the BACE II project, which will double our production capabilities of AlbuRx®, increasing patient supply across the globe.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$239.29 |
Change
0.190(0.08%) |
Mkt cap ! $115.8B | |||
| Open | High | Low | Value | Volume |
| $238.55 | $241.28 | $237.66 | $133.2M | 556.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 357 | $239.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $239.32 | 982 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |